McCain has decided to discontinue treatment, his family said. — -- Sen. John McCain has decided to discontinue treatment of his brain cancer, his family said Friday. McCain was diagnosed last ...

Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain cancer therapy.

Cintredekin besudotox targets IL-13 alpha-2 receptor in glioblastoma, aiming to spare healthy brain tissue while destroying cancer cells. Orphan drug designation offers benefits like lower fees and ...

(RTTNews) - Novocure (NVCR) an oncology company, has received approval from the FDA for its new Head Flexible Electrode transducer arrays, designed for use with its Optune Gio device, which is used in ...

A Ludwig Cancer Research study using human tissue samples and mouse models has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous ...

(MENAFN- GlobeNewsWire - Nasdaq) Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma multiforme treatments, with advances in ...

Bestselling author Sophie Kinsella, known for her “Confessions of a Shopaholic” series, died on Wednesday (December 10), at the age of 55, battling glioblastoma, an aggressive form of brain cancer.

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis. Its ...

Exousia Pro's exome-based treatment for GBM has received FDA orphan drug designation, offering incentives like tax benefits and market exclusivity. The company's exosomal technology delivers genetic ...